nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—F2—leg—chronic obstructive pulmonary disease	0.0333	0.259	CbGeAlD
Dabigatran etexilate—CES2—respiratory system—chronic obstructive pulmonary disease	0.00923	0.0716	CbGeAlD
Dabigatran etexilate—F2—respiratory system—chronic obstructive pulmonary disease	0.00828	0.0642	CbGeAlD
Dabigatran etexilate—CES1—respiratory system—chronic obstructive pulmonary disease	0.0076	0.059	CbGeAlD
Dabigatran etexilate—CES2—bronchus—chronic obstructive pulmonary disease	0.0076	0.0589	CbGeAlD
Dabigatran etexilate—CES2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00743	0.0577	CbGeAlD
Dabigatran etexilate—F2—connective tissue—chronic obstructive pulmonary disease	0.00729	0.0565	CbGeAlD
Dabigatran etexilate—CES2—trachea—chronic obstructive pulmonary disease	0.00682	0.0529	CbGeAlD
Dabigatran etexilate—NQO2—bronchus—chronic obstructive pulmonary disease	0.00679	0.0527	CbGeAlD
Dabigatran etexilate—CES1—connective tissue—chronic obstructive pulmonary disease	0.00669	0.0519	CbGeAlD
Dabigatran etexilate—NQO2—trachea—chronic obstructive pulmonary disease	0.0061	0.0473	CbGeAlD
Dabigatran etexilate—CES2—lung—chronic obstructive pulmonary disease	0.0049	0.038	CbGeAlD
Dabigatran etexilate—F2—lung—chronic obstructive pulmonary disease	0.0044	0.0341	CbGeAlD
Dabigatran etexilate—NQO2—lung—chronic obstructive pulmonary disease	0.00438	0.034	CbGeAlD
Dabigatran etexilate—CES1—lung—chronic obstructive pulmonary disease	0.00404	0.0313	CbGeAlD
Dabigatran etexilate—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.00178	0.0138	CbGeAlD
Dabigatran etexilate—Infection—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.0025	CcSEcCtD
Dabigatran etexilate—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.0014	0.00249	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.0014	0.00249	CcSEcCtD
Dabigatran etexilate—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00138	0.00247	CcSEcCtD
Dabigatran etexilate—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00138	0.00247	CcSEcCtD
Dabigatran etexilate—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00138	0.00247	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00138	0.00247	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00137	0.00246	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00137	0.00245	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00243	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00243	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00243	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00243	CcSEcCtD
Dabigatran etexilate—Contusion—Prednisone—chronic obstructive pulmonary disease	0.00135	0.00242	CcSEcCtD
Dabigatran etexilate—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00134	0.0024	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00133	0.00238	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00133	0.00238	CcSEcCtD
Dabigatran etexilate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00133	0.00238	CcSEcCtD
Dabigatran etexilate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00133	0.00238	CcSEcCtD
Dabigatran etexilate—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00132	0.00236	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00236	CcSEcCtD
Dabigatran etexilate—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.00236	CcSEcCtD
Dabigatran etexilate—ABCB1—trachea—chronic obstructive pulmonary disease	0.00132	0.0102	CbGeAlD
Dabigatran etexilate—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00132	0.00235	CcSEcCtD
Dabigatran etexilate—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00235	CcSEcCtD
Dabigatran etexilate—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00235	CcSEcCtD
Dabigatran etexilate—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00131	0.00233	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.0013	0.00233	CcSEcCtD
Dabigatran etexilate—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.0013	0.00233	CcSEcCtD
Dabigatran etexilate—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00231	CcSEcCtD
Dabigatran etexilate—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00129	0.0023	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.0023	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00229	CcSEcCtD
Dabigatran etexilate—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00127	0.00227	CcSEcCtD
Dabigatran etexilate—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00127	0.00227	CcSEcCtD
Dabigatran etexilate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00125	0.00224	CcSEcCtD
Dabigatran etexilate—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00221	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00124	0.00221	CcSEcCtD
Dabigatran etexilate—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00218	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00121	0.00216	CcSEcCtD
Dabigatran etexilate—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00214	CcSEcCtD
Dabigatran etexilate—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00214	CcSEcCtD
Dabigatran etexilate—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.00214	CcSEcCtD
Dabigatran etexilate—F2—Complement and Coagulation Cascades—PLAU—chronic obstructive pulmonary disease	0.0012	0.00385	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00118	0.0038	CbGpPWpGaD
Dabigatran etexilate—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.00211	CcSEcCtD
Dabigatran etexilate—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00117	0.0021	CcSEcCtD
Dabigatran etexilate—F2—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	0.00117	0.00376	CbGpPWpGaD
Dabigatran etexilate—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00117	0.00209	CcSEcCtD
Dabigatran etexilate—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00207	CcSEcCtD
Dabigatran etexilate—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00207	CcSEcCtD
Dabigatran etexilate—F2—Syndecan-4-mediated signaling events—MMP9—chronic obstructive pulmonary disease	0.00116	0.00372	CbGpPWpGaD
Dabigatran etexilate—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00115	0.00206	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00205	CcSEcCtD
Dabigatran etexilate—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00205	CcSEcCtD
Dabigatran etexilate—Cough—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00205	CcSEcCtD
Dabigatran etexilate—F2—PAR1-mediated thrombin signaling events—NOS3—chronic obstructive pulmonary disease	0.00114	0.00366	CbGpPWpGaD
Dabigatran etexilate—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00203	CcSEcCtD
Dabigatran etexilate—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.00203	CcSEcCtD
Dabigatran etexilate—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00202	CcSEcCtD
Dabigatran etexilate—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00202	CcSEcCtD
Dabigatran etexilate—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00202	CcSEcCtD
Dabigatran etexilate—CES1—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.00113	0.00363	CbGpPWpGaD
Dabigatran etexilate—Cough—Montelukast—chronic obstructive pulmonary disease	0.00112	0.002	CcSEcCtD
Dabigatran etexilate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00112	0.002	CcSEcCtD
Dabigatran etexilate—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00112	0.002	CcSEcCtD
Dabigatran etexilate—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.002	CcSEcCtD
Dabigatran etexilate—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00112	0.002	CcSEcCtD
Dabigatran etexilate—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.002	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00111	0.00199	CcSEcCtD
Dabigatran etexilate—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00199	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00111	0.00198	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.00198	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.0011	0.00354	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.0011	0.00353	CbGpPWpGaD
Dabigatran etexilate—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00196	CcSEcCtD
Dabigatran etexilate—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00109	0.00196	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00195	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00109	0.00194	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00194	CcSEcCtD
Dabigatran etexilate—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00193	CcSEcCtD
Dabigatran etexilate—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00193	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00191	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00191	CcSEcCtD
Dabigatran etexilate—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00191	CcSEcCtD
Dabigatran etexilate—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00191	CcSEcCtD
Dabigatran etexilate—Infection—Formoterol—chronic obstructive pulmonary disease	0.00106	0.0019	CcSEcCtD
Dabigatran etexilate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.0019	CcSEcCtD
Dabigatran etexilate—UGT2B7—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.00106	0.0034	CbGpPWpGaD
Dabigatran etexilate—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00189	CcSEcCtD
Dabigatran etexilate—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00189	CcSEcCtD
Dabigatran etexilate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00188	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00188	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00188	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00187	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00187	CcSEcCtD
Dabigatran etexilate—Infection—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00186	CcSEcCtD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.00104	0.00334	CbGpPWpGaD
Dabigatran etexilate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00186	CcSEcCtD
Dabigatran etexilate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00186	CcSEcCtD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—ALB—chronic obstructive pulmonary disease	0.00104	0.00334	CbGpPWpGaD
Dabigatran etexilate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.00185	CcSEcCtD
Dabigatran etexilate—UGT1A9—Phase II conjugation—CYP1A2—chronic obstructive pulmonary disease	0.00103	0.00331	CbGpPWpGaD
Dabigatran etexilate—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00184	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00184	CcSEcCtD
Dabigatran etexilate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00182	CcSEcCtD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.00102	0.00326	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00101	0.00325	CbGpPWpGaD
Dabigatran etexilate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00181	CcSEcCtD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—NOS3—chronic obstructive pulmonary disease	0.00101	0.00324	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.00101	0.00323	CbGpPWpGaD
Dabigatran etexilate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.001	0.0018	CcSEcCtD
Dabigatran etexilate—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.001	0.00179	CcSEcCtD
Dabigatran etexilate—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.001	0.00179	CcSEcCtD
Dabigatran etexilate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000996	0.00178	CcSEcCtD
Dabigatran etexilate—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000995	0.00178	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000992	0.00177	CcSEcCtD
Dabigatran etexilate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000982	0.00176	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000978	0.00175	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000976	0.00174	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000976	0.00174	CcSEcCtD
Dabigatran etexilate—UGT2B7—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.000972	0.00312	CbGpPWpGaD
Dabigatran etexilate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000963	0.00172	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000956	0.00171	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000955	0.00171	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000955	0.00171	CcSEcCtD
Dabigatran etexilate—UGT2B7—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000954	0.00306	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—APIP—chronic obstructive pulmonary disease	0.000952	0.00306	CbGpPWpGaD
Dabigatran etexilate—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000946	0.00169	CcSEcCtD
Dabigatran etexilate—ABCB1—lung—chronic obstructive pulmonary disease	0.000945	0.00733	CbGeAlD
Dabigatran etexilate—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000945	0.00169	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000943	0.00168	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000943	0.00168	CcSEcCtD
Dabigatran etexilate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000939	0.00168	CcSEcCtD
Dabigatran etexilate—UGT1A9—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.000936	0.003	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000935	0.003	CbGpPWpGaD
Dabigatran etexilate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000931	0.00166	CcSEcCtD
Dabigatran etexilate—F2—Complement and Coagulation Cascades—SERPINE1—chronic obstructive pulmonary disease	0.000927	0.00298	CbGpPWpGaD
Dabigatran etexilate—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000925	0.00165	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000925	0.00165	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000924	0.00165	CcSEcCtD
Dabigatran etexilate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000923	0.00165	CcSEcCtD
Dabigatran etexilate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000923	0.00165	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000921	0.00165	CcSEcCtD
Dabigatran etexilate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000916	0.00164	CcSEcCtD
Dabigatran etexilate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000916	0.00164	CcSEcCtD
Dabigatran etexilate—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.000916	0.00294	CbGpPWpGaD
Dabigatran etexilate—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000906	0.00162	CcSEcCtD
Dabigatran etexilate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000905	0.00162	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000902	0.00161	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000897	0.0016	CcSEcCtD
Dabigatran etexilate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000895	0.0016	CcSEcCtD
Dabigatran etexilate—UGT1A9—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000894	0.00287	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000893	0.00287	CbGpPWpGaD
Dabigatran etexilate—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000892	0.00159	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00089	0.00159	CcSEcCtD
Dabigatran etexilate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000887	0.00159	CcSEcCtD
Dabigatran etexilate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000887	0.00158	CcSEcCtD
Dabigatran etexilate—UGT2B7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000883	0.00283	CbGpPWpGaD
Dabigatran etexilate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000882	0.00158	CcSEcCtD
Dabigatran etexilate—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000879	0.00157	CcSEcCtD
Dabigatran etexilate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000878	0.00157	CcSEcCtD
Dabigatran etexilate—F2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000876	0.00281	CbGpPWpGaD
Dabigatran etexilate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000876	0.00156	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000876	0.00156	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000873	0.00156	CcSEcCtD
Dabigatran etexilate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000872	0.00156	CcSEcCtD
Dabigatran etexilate—F2—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000869	0.00279	CbGpPWpGaD
Dabigatran etexilate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000865	0.00155	CcSEcCtD
Dabigatran etexilate—UGT1A9—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.00086	0.00276	CbGpPWpGaD
Dabigatran etexilate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000858	0.00153	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000858	0.00153	CcSEcCtD
Dabigatran etexilate—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000858	0.00153	CcSEcCtD
Dabigatran etexilate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000851	0.00152	CcSEcCtD
Dabigatran etexilate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000851	0.00152	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000847	0.00272	CbGpPWpGaD
Dabigatran etexilate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000847	0.00151	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000847	0.00151	CcSEcCtD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000847	0.00272	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	0.000846	0.00272	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—ALB—chronic obstructive pulmonary disease	0.000846	0.00272	CbGpPWpGaD
Dabigatran etexilate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000844	0.00151	CcSEcCtD
Dabigatran etexilate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000837	0.0015	CcSEcCtD
Dabigatran etexilate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000836	0.00149	CcSEcCtD
Dabigatran etexilate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000836	0.00149	CcSEcCtD
Dabigatran etexilate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000833	0.00149	CcSEcCtD
Dabigatran etexilate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000831	0.00149	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000829	0.00148	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000827	0.00148	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000821	0.00147	CcSEcCtD
Dabigatran etexilate—UGT1A9—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000818	0.00263	CbGpPWpGaD
Dabigatran etexilate—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000816	0.00146	CcSEcCtD
Dabigatran etexilate—F2—Cell surface interactions at the vascular wall—MMP1—chronic obstructive pulmonary disease	0.000807	0.00259	CbGpPWpGaD
Dabigatran etexilate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000803	0.00144	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.0008	0.00143	CcSEcCtD
Dabigatran etexilate—UGT1A9—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.00079	0.00254	CbGpPWpGaD
Dabigatran etexilate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000789	0.00141	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000789	0.00141	CcSEcCtD
Dabigatran etexilate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000788	0.00141	CcSEcCtD
Dabigatran etexilate—CES2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000781	0.00251	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000775	0.00249	CbGpPWpGaD
Dabigatran etexilate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000773	0.00138	CcSEcCtD
Dabigatran etexilate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000768	0.00137	CcSEcCtD
Dabigatran etexilate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000768	0.00137	CcSEcCtD
Dabigatran etexilate—UGT1A9—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.00076	0.00244	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.00076	0.00244	CbGpPWpGaD
Dabigatran etexilate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000758	0.00135	CcSEcCtD
Dabigatran etexilate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000758	0.00135	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000756	0.00135	CcSEcCtD
Dabigatran etexilate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000753	0.00134	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000745	0.00133	CcSEcCtD
Dabigatran etexilate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000742	0.00133	CcSEcCtD
Dabigatran etexilate—UGT2B7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000742	0.00238	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000734	0.00236	CbGpPWpGaD
Dabigatran etexilate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000733	0.00131	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000733	0.00131	CcSEcCtD
Dabigatran etexilate—UGT2B7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000732	0.00235	CbGpPWpGaD
Dabigatran etexilate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000726	0.0013	CcSEcCtD
Dabigatran etexilate—UGT1A9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000726	0.00233	CbGpPWpGaD
Dabigatran etexilate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000718	0.00128	CcSEcCtD
Dabigatran etexilate—UGT1A9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000717	0.0023	CbGpPWpGaD
Dabigatran etexilate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000716	0.00128	CcSEcCtD
Dabigatran etexilate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000708	0.00127	CcSEcCtD
Dabigatran etexilate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000708	0.00127	CcSEcCtD
Dabigatran etexilate—UGT2B7—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000706	0.00227	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.000696	0.00224	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000696	0.00223	CbGpPWpGaD
Dabigatran etexilate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000694	0.00124	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000692	0.00124	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.000688	0.00221	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000684	0.0022	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000682	0.00219	CbGpPWpGaD
Dabigatran etexilate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000681	0.00122	CcSEcCtD
Dabigatran etexilate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000681	0.00122	CcSEcCtD
Dabigatran etexilate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000675	0.00121	CcSEcCtD
Dabigatran etexilate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000675	0.00121	CcSEcCtD
Dabigatran etexilate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000675	0.00121	CcSEcCtD
Dabigatran etexilate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000675	0.00121	CcSEcCtD
Dabigatran etexilate—F2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000673	0.00216	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000672	0.00216	CbGpPWpGaD
Dabigatran etexilate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000671	0.0012	CcSEcCtD
Dabigatran etexilate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000671	0.0012	CcSEcCtD
Dabigatran etexilate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000669	0.0012	CcSEcCtD
Dabigatran etexilate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000667	0.00119	CcSEcCtD
Dabigatran etexilate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000661	0.00118	CcSEcCtD
Dabigatran etexilate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000661	0.00118	CcSEcCtD
Dabigatran etexilate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000657	0.00117	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000652	0.00116	CcSEcCtD
Dabigatran etexilate—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000649	0.00116	CcSEcCtD
Dabigatran etexilate—UGT2B7—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000648	0.00208	CbGpPWpGaD
Dabigatran etexilate—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000648	0.00116	CcSEcCtD
Dabigatran etexilate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000643	0.00115	CcSEcCtD
Dabigatran etexilate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000638	0.00114	CcSEcCtD
Dabigatran etexilate—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000637	0.00114	CcSEcCtD
Dabigatran etexilate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000637	0.00114	CcSEcCtD
Dabigatran etexilate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000636	0.00114	CcSEcCtD
Dabigatran etexilate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000636	0.00114	CcSEcCtD
Dabigatran etexilate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000634	0.00113	CcSEcCtD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000632	0.00203	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.000631	0.00203	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000631	0.00203	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.000626	0.00201	CbGpPWpGaD
Dabigatran etexilate—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000625	0.00112	CcSEcCtD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—chronic obstructive pulmonary disease	0.000624	0.002	CbGpPWpGaD
Dabigatran etexilate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000623	0.00111	CcSEcCtD
Dabigatran etexilate—UGT2B7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000619	0.00199	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	0.000614	0.00197	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GC—chronic obstructive pulmonary disease	0.000614	0.00197	CbGpPWpGaD
Dabigatran etexilate—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000614	0.0011	CcSEcCtD
Dabigatran etexilate—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.000613	0.00197	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00061	0.00196	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000603	0.00194	CbGpPWpGaD
Dabigatran etexilate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000601	0.00107	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000596	0.00107	CcSEcCtD
Dabigatran etexilate—UGT1A9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000595	0.00191	CbGpPWpGaD
Dabigatran etexilate—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000593	0.00106	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000583	0.00104	CcSEcCtD
Dabigatran etexilate—F2—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000581	0.00187	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000581	0.00187	CbGpPWpGaD
Dabigatran etexilate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00058	0.00104	CcSEcCtD
Dabigatran etexilate—F2—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000577	0.00185	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000576	0.00185	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000573	0.00184	CbGpPWpGaD
Dabigatran etexilate—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000571	0.00102	CcSEcCtD
Dabigatran etexilate—UGT2B15—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000571	0.00183	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.00057	0.00183	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000569	0.00183	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000565	0.00182	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000561	0.0018	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000547	0.00176	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000541	0.00174	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000539	0.00173	CbGpPWpGaD
Dabigatran etexilate—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000538	0.000962	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000536	0.000958	CcSEcCtD
Dabigatran etexilate—UGT2B7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000532	0.00171	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.00053	0.0017	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000527	0.00169	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000519	0.00167	CbGpPWpGaD
Dabigatran etexilate—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000516	0.000923	CcSEcCtD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000516	0.00166	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00051	0.00164	CbGpPWpGaD
Dabigatran etexilate—F2—Post-translational protein modification—PLAUR—chronic obstructive pulmonary disease	0.000507	0.00163	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	0.000505	0.00162	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000505	0.00162	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000503	0.00161	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.000499	0.0016	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000496	0.00159	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	0.000495	0.00159	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.00049	0.00157	CbGpPWpGaD
Dabigatran etexilate—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000477	0.000853	CcSEcCtD
Dabigatran etexilate—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000472	0.000843	CcSEcCtD
Dabigatran etexilate—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000463	0.000828	CcSEcCtD
Dabigatran etexilate—UGT1A9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000462	0.00148	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000461	0.00148	CbGpPWpGaD
Dabigatran etexilate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000461	0.000823	CcSEcCtD
Dabigatran etexilate—CES1—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.00046	0.00148	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000456	0.00146	CbGpPWpGaD
Dabigatran etexilate—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000454	0.000811	CcSEcCtD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000451	0.00145	CbGpPWpGaD
Dabigatran etexilate—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000446	0.000797	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—TP53—chronic obstructive pulmonary disease	0.00044	0.00141	CbGpPWpGaD
Dabigatran etexilate—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00044	0.000786	CcSEcCtD
Dabigatran etexilate—UGT1A9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000438	0.00141	CbGpPWpGaD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000437	0.00078	CcSEcCtD
Dabigatran etexilate—F2—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000436	0.0014	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000434	0.00139	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000432	0.00139	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000428	0.00137	CbGpPWpGaD
Dabigatran etexilate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000427	0.000764	CcSEcCtD
Dabigatran etexilate—F2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000425	0.00137	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000423	0.00136	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000422	0.00136	CbGpPWpGaD
Dabigatran etexilate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000422	0.000753	CcSEcCtD
Dabigatran etexilate—Infection—Prednisone—chronic obstructive pulmonary disease	0.000419	0.000748	CcSEcCtD
Dabigatran etexilate—Shock—Prednisone—chronic obstructive pulmonary disease	0.000415	0.000741	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000413	0.000739	CcSEcCtD
Dabigatran etexilate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000409	0.000732	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—IL6—chronic obstructive pulmonary disease	0.000403	0.00129	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000397	0.00127	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000395	0.00127	CbGpPWpGaD
Dabigatran etexilate—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000384	0.000686	CcSEcCtD
Dabigatran etexilate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000384	0.000685	CcSEcCtD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000382	0.00123	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000378	0.00122	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000377	0.00121	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000375	0.00121	CbGpPWpGaD
Dabigatran etexilate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000371	0.000663	CcSEcCtD
Dabigatran etexilate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000366	0.000654	CcSEcCtD
Dabigatran etexilate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000365	0.000653	CcSEcCtD
Dabigatran etexilate—F2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000364	0.00117	CbGpPWpGaD
Dabigatran etexilate—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000363	0.000649	CcSEcCtD
Dabigatran etexilate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000363	0.000649	CcSEcCtD
Dabigatran etexilate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00036	0.000644	CcSEcCtD
Dabigatran etexilate—UGT1A9—Metabolism—APIP—chronic obstructive pulmonary disease	0.000352	0.00113	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.00035	0.00112	CbGpPWpGaD
Dabigatran etexilate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000345	0.000616	CcSEcCtD
Dabigatran etexilate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000345	0.000616	CcSEcCtD
Dabigatran etexilate—F2—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000339	0.00109	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000335	0.00108	CbGpPWpGaD
Dabigatran etexilate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000335	0.000598	CcSEcCtD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000334	0.00107	CbGpPWpGaD
Dabigatran etexilate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000333	0.000595	CcSEcCtD
Dabigatran etexilate—UGT2B15—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000331	0.00106	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00033	0.00106	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000326	0.00105	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000322	0.00103	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000322	0.00103	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.00032	0.00103	CbGpPWpGaD
Dabigatran etexilate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000311	0.000555	CcSEcCtD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000308	0.000989	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000306	0.000983	CbGpPWpGaD
Dabigatran etexilate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000302	0.00054	CcSEcCtD
Dabigatran etexilate—UGT2B15—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000302	0.000971	CbGpPWpGaD
Dabigatran etexilate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000298	0.000533	CcSEcCtD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000295	0.000946	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000293	0.000942	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000291	0.000934	CbGpPWpGaD
Dabigatran etexilate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000515	CcSEcCtD
Dabigatran etexilate—UGT2B7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000287	0.000923	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GC—chronic obstructive pulmonary disease	0.00028	0.000898	CbGpPWpGaD
Dabigatran etexilate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000279	0.000498	CcSEcCtD
Dabigatran etexilate—UGT2B15—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000279	0.000895	CbGpPWpGaD
Dabigatran etexilate—F2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	0.000273	0.000878	CbGpPWpGaD
Dabigatran etexilate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000268	0.000479	CcSEcCtD
Dabigatran etexilate—F2—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000268	0.000861	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000266	0.000855	CbGpPWpGaD
Dabigatran etexilate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000266	0.000475	CcSEcCtD
Dabigatran etexilate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000266	0.000474	CcSEcCtD
Dabigatran etexilate—UGT2B7—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000264	0.000849	CbGpPWpGaD
Dabigatran etexilate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000264	0.000472	CcSEcCtD
Dabigatran etexilate—UGT2B7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00026	0.000834	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000258	0.000827	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000255	0.000817	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000251	0.000807	CbGpPWpGaD
Dabigatran etexilate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00025	0.000447	CcSEcCtD
Dabigatran etexilate—F2—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000241	0.000773	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000233	0.00075	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000232	0.000746	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000232	0.000744	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000229	0.000736	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GC—chronic obstructive pulmonary disease	0.000227	0.000729	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000222	0.000712	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000219	0.000702	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	0.000216	0.000694	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000215	0.00069	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000215	0.000689	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000214	0.000686	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000211	0.000678	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	0.000207	0.000665	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000207	0.000663	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000204	0.000655	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000203	0.000653	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000203	0.000651	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000202	0.00065	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000197	0.000633	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000195	0.000627	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000184	0.000591	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	0.000175	0.000563	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000172	0.000552	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000168	0.00054	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000167	0.000537	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000166	0.000535	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000166	0.000533	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000166	0.000532	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000164	0.000528	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000162	0.000519	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	0.000161	0.000517	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000159	0.000509	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000157	0.000505	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000157	0.000505	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000157	0.000503	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000153	0.00049	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000151	0.000485	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	0.00015	0.000483	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000149	0.00048	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000144	0.000462	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000138	0.000442	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ALB—chronic obstructive pulmonary disease	0.000138	0.000442	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000132	0.000423	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000131	0.00042	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000127	0.000407	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000124	0.000398	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000123	0.000394	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000115	0.000369	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000114	0.000367	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000114	0.000367	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000112	0.000359	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	0.000111	0.000355	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000107	0.000344	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000107	0.000343	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000106	0.00034	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000105	0.000337	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000104	0.000335	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	0.000104	0.000335	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000103	0.000331	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.87e-05	0.000317	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.73e-05	0.000312	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.69e-05	0.000311	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.22e-05	0.000296	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.89e-05	0.000285	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.82e-05	0.000283	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	8.66e-05	0.000278	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TP53—chronic obstructive pulmonary disease	8.63e-05	0.000277	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.6e-05	0.000276	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.48e-05	0.000272	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.31e-05	0.000267	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.07e-05	0.000259	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.02e-05	0.000257	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	7.95e-05	0.000255	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.9e-05	0.000254	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	7.79e-05	0.00025	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.72e-05	0.000248	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.49e-05	0.000241	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	7.42e-05	0.000238	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.17e-05	0.00023	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	6.54e-05	0.00021	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ALB—chronic obstructive pulmonary disease	6.27e-05	0.000201	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—NOS3—chronic obstructive pulmonary disease	6e-05	0.000193	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.9e-05	0.000189	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.69e-05	0.000183	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.63e-05	0.000181	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.63e-05	0.000181	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.37e-05	0.000173	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	5.13e-05	0.000165	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ALB—chronic obstructive pulmonary disease	5.09e-05	0.000164	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.99e-05	0.00016	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NOS3—chronic obstructive pulmonary disease	4.87e-05	0.000156	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.77e-05	0.000153	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.73e-05	0.000152	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.53e-05	0.000146	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.31e-05	0.000138	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.95e-05	0.000127	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.89e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.87e-05	0.000124	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.63e-05	0.000116	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.55e-05	0.000114	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.48e-05	0.000112	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.44e-05	0.00011	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.93e-05	9.4e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.68e-05	8.6e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	2.34e-05	7.5e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.23e-05	7.18e-05	CbGpPWpGaD
